Hurley Capital LLC Makes New $28,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 55 shares of the healthcare conglomerate’s stock, valued at approximately $28,000.

Other hedge funds have also added to or reduced their stakes in the company. Howard Capital Management Group LLC bought a new position in UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. grew its holdings in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth about $319,000. EP Wealth Advisors LLC increased its holdings in UnitedHealth Group by 3.6% in the 3rd quarter. EP Wealth Advisors LLC now owns 86,650 shares of the healthcare conglomerate’s stock worth $50,662,000 after acquiring an additional 2,999 shares in the last quarter. Finally, Hendershot Investments Inc. lifted its holdings in UnitedHealth Group by 0.8% during the third quarter. Hendershot Investments Inc. now owns 41,575 shares of the healthcare conglomerate’s stock valued at $24,308,000 after purchasing an additional 315 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on UNH. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $524.94 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm’s 50-day moving average is $509.24 and its 200 day moving average is $542.12. The company has a market capitalization of $480.17 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.